abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding abrdn Life Sciences Investors changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 63 | −1 |
| Shares | 3.67M | 15.5K | 4.28M | +618.0K (+16.9%) |
| Value | $52.3M | $220.0K | $58.4M | +$6.34M (+12.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held abrdn Life Sciences Investors at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 1607 Capital Partners, LLC | 84,901 | $1.16M | 0.09% |
| Millennium Management LLC | 35,218 | $481.0K | 0.00% |
| Raymond James Trust N.A. | 12,157 | $166.0K | 0.01% |
| CNH Partners LLC | 10,030 | $137.0K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 1,024 | $13.0K | 0.01% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (7)
Institutions that held abrdn Life Sciences Investors at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Hennion & Walsh Asset Management, Inc. | 28,224 | $402.0K |
| Cambridge Investment Research Advisors, Inc. | 15,278 | $217.0K |
| CoreCap Advisors, LLC | 559 | $8.00K |
| Northwestern Mutual Wealth Management Co | 445 | $6.00K |
| Prospera Financial Services Inc | 300 | $4.00K |
| WFA of San Diego, LLC | 300 | $4.00K |
| Laurel Wealth Advisors LLC | 65 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held abrdn Life Sciences Investors at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Titus Wealth Management | 15,455 | $220.0K |